We are live on ! Find out more
NRIX icon

Nurix Therapeutics
NRIX

163 hedge funds and large institutions have $1.01B invested in Nurix Therapeutics in 2025 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 69 increasing their positions, 43 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

895% more call options, than puts

Call options by funds: $1.72M | Put options by funds: $173K

60% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 43

4.37% more ownership

Funds ownership: 111.48% → 115.85% (+4.4%)

0% more capital invested

Capital invested by funds: $1.01B → $1.01B (+$825K)

4% less funds holding

Funds holding: 170 → 163 (-7)

23% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 30

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
163
Holders Change
-7
Holders Change %
-4.12%
% of All Funds
2.15%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
23
Increased
69
Reduced
43
Closed
30
Calls
$1.72M
Puts
$173K
Net Calls
+$1.55M
Net Calls Change
+$867K

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$37.7M
2
UBS Group
UBS Group
Switzerland
+$9.9M
3
VPC
Vestal Point Capital
New York
+$9.45M
4
PA
Perceptive Advisors
New York
+$8.64M
5
Morgan Stanley
Morgan Stanley
New York
+$7.57M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$18.6M
2
RCM
RA Capital Management
Massachusetts
-$15.8M
3
BlackRock
BlackRock
New York
-$12.7M
4
DCM
Driehaus Capital Management
Illinois
-$8.51M
5
SC
Samlyn Capital
New York
-$6.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
RIL
151
Rothschild Investment LLC
Illinois
$2.22K +$378 +35 +22%
JSAM
152
J. Safra Asset Management
New York
$1.8K +$659 +61 +63%
PNC Financial Services Group
153
PNC Financial Services Group
Pennsylvania
$1.48K +$821 +76 +141%
EWA
154
EverSource Wealth Advisors
Alabama
$1.47K +$1.39K +129 New
PFBT
155
Parkside Financial Bank & Trust
Missouri
$1.14K +$1.08K +100 New
Carson Wealth (CWM LLC)
156
Carson Wealth (CWM LLC)
Nebraska
$1K +$519 +48 +600%
SAM
157
Smartleaf Asset Management
Massachusetts
$616 -$1.75K -162 -75%
SIC
158
SJS Investment Consulting
Ohio
$570 – – –
IA
159
IFP Advisors
Florida
$375 – – –
CIBC Private Wealth Group
160
CIBC Private Wealth Group
Georgia
$308 +$292 +27 New
SS
161
SBI Securities
Japan
$205 +$195 +18 New
FFA
162
Farther Finance Advisors
California
$103 +$97 +9 New
TPWA
163
Twin Peaks Wealth Advisors
California
$10 +$11 +1 New
RCM
164
RA Capital Management
Massachusetts
– -$15.8M -1,333,333 Closed
DCM
165
Driehaus Capital Management
Illinois
– -$8.51M -715,940 Closed
SC
166
Samlyn Capital
New York
– -$6.12M -515,103 Closed
TC
167
TwinBeech Capital
New York
– -$2.01M -169,280 Closed
CSS
168
Cubist Systematic Strategies
Connecticut
– -$1.4M -117,615 Closed
OM
169
Opaleye Management
Massachusetts
– -$1.37M -115,000 Closed
JF
170
Jump Financial
Illinois
– -$904K -76,060 Closed
D.E. Shaw & Co
171
D.E. Shaw & Co
New York
– -$712K -59,923 Closed
HSA
172
Hussman Strategic Advisors
Maryland
– -$499K -42,000 Closed
EC
173
EntryPoint Capital
New York
– -$446K -37,559 Closed
CF
174
Corebridge Financial
Texas
– -$438K -36,849 Closed
YIH
175
Y-Intercept (HK)
Hong Kong
– -$374K -31,458 Closed
4 5 6
7
8

NRIX Hedge Fund Activity: Q2 2025 in Review

163 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Nurix Therapeutics (NRIX) for Q2 2025, worth a combined $1.01B — up 0.08% from $1.01B a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of NRIX and 23 opened new positions — a net loss of 7 holders — while 43 trimmed existing stakes and 69 added.

The largest buyer was Point72 Asset Management, adding an estimated $37.7M. The largest seller was Wellington Management Group, cutting an estimated $18.6M.

  • 163 institutional investors held Nurix Therapeutics (NRIX) as of Q2 2025, down from 170 in Q1 2025.
  • Funds reported $1.01B of Nurix Therapeutics stock for Q2 2025, up 0.08% quarter-over-quarter.
  • 23 funds opened new Nurix Therapeutics positions in Q2 2025 and 30 closed out, a net change of -7 holders.
  • The largest Nurix Therapeutics buyer in Q2 2025 was Point72 Asset Management, an estimated $37.7M added.
  • The largest Nurix Therapeutics seller in Q2 2025 was Wellington Management Group, an estimated $18.6M sold.

Based on aggregated 13F filings for Q2 2025.